0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Diagnostic Imaging Clinical Trials - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: December 2024
|
Report Code: QYRE-Auto-36D15165
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Diagnostic Imaging Clinical Trials Market Insights Forecast to 2029
BUY CHAPTERS

Diagnostic Imaging Clinical Trials - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-36D15165
Report
December 2024
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Diagnostic Imaging Clinical Trials - Market Size

The global market for Diagnostic Imaging Clinical Trials was estimated to be worth US$ 1204 million in 2023 and is forecast to a readjusted size of US$ 1819.5 million by 2030 with a CAGR of 6.7% during the forecast period 2024-2030

Diagnostic Imaging Clinical Trials - Market

Diagnostic Imaging Clinical Trials - Market

Diagnostic imaging clinical trials address questions about what type of imaging test will best detect disease when it is suspected or will help monitor known disease or monitor a therapy to evaluate whether it is working.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Diagnostic Imaging Clinical Trials, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Diagnostic Imaging Clinical Trials by region & country, by Type, and by Application.
The Diagnostic Imaging Clinical Trials market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Imaging Clinical Trials.
Market Segmentation

Scope of Diagnostic Imaging Clinical Trials - Market Report

Report Metric Details
Report Name Diagnostic Imaging Clinical Trials - Market
Forecasted market size in 2030 US$ 1819.5 million
CAGR 6.7%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
  • Hospital
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company ICON, Parexel, BioTelemetry, ERT, McLaren, Bioclinica, ProScan Imaging, Radiant Sage, Micron, Inc., Imaging Endpoints, Intrinsic Imaging, Median Technologies
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Diagnostic Imaging Clinical Trials manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Diagnostic Imaging Clinical Trials in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Diagnostic Imaging Clinical Trials in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Diagnostic Imaging Clinical Trials - Market size in 2030?

Ans: The Diagnostic Imaging Clinical Trials - Market size in 2030 will be US$ 1819.5 million.

Who are the main players in the Diagnostic Imaging Clinical Trials - Market report?

Ans: The main players in the Diagnostic Imaging Clinical Trials - Market are ICON, Parexel, BioTelemetry, ERT, McLaren, Bioclinica, ProScan Imaging, Radiant Sage, Micron, Inc., Imaging Endpoints, Intrinsic Imaging, Median Technologies

What are the Application segmentation covered in the Diagnostic Imaging Clinical Trials - Market report?

Ans: The Applications covered in the Diagnostic Imaging Clinical Trials - Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Diagnostic Imaging Clinical Trials - Market report?

Ans: The Types covered in the Diagnostic Imaging Clinical Trials - Market report are Radiological Imaging Diagnosis, Non-radioactive Imaging Diagnosis

Recommended Reports

Imaging Diagnostics

Clinical Diagnostics

Oncology & Specialized

1 Market Overview
1.1 Diagnostic Imaging Clinical Trials Product Introduction
1.2 Global Diagnostic Imaging Clinical Trials Market Size Forecast
1.3 Diagnostic Imaging Clinical Trials Market Trends & Drivers
1.3.1 Diagnostic Imaging Clinical Trials Industry Trends
1.3.2 Diagnostic Imaging Clinical Trials Market Drivers & Opportunity
1.3.3 Diagnostic Imaging Clinical Trials Market Challenges
1.3.4 Diagnostic Imaging Clinical Trials Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Diagnostic Imaging Clinical Trials Players Revenue Ranking (2023)
2.2 Global Diagnostic Imaging Clinical Trials Revenue by Company (2019-2024)
2.3 Key Companies Diagnostic Imaging Clinical Trials Manufacturing Base Distribution and Headquarters
2.4 Key Companies Diagnostic Imaging Clinical Trials Product Offered
2.5 Key Companies Time to Begin Mass Production of Diagnostic Imaging Clinical Trials
2.6 Diagnostic Imaging Clinical Trials Market Competitive Analysis
2.6.1 Diagnostic Imaging Clinical Trials Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Diagnostic Imaging Clinical Trials Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Imaging Clinical Trials as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Radiological Imaging Diagnosis
3.1.2 Non-radioactive Imaging Diagnosis
3.2 Global Diagnostic Imaging Clinical Trials Sales Value by Type
3.2.1 Global Diagnostic Imaging Clinical Trials Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Diagnostic Imaging Clinical Trials Sales Value, by Type (2019-2030)
3.2.3 Global Diagnostic Imaging Clinical Trials Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Diagnostic Imaging Clinical Trials Sales Value by Application
4.2.1 Global Diagnostic Imaging Clinical Trials Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Diagnostic Imaging Clinical Trials Sales Value, by Application (2019-2030)
4.2.3 Global Diagnostic Imaging Clinical Trials Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Diagnostic Imaging Clinical Trials Sales Value by Region
5.1.1 Global Diagnostic Imaging Clinical Trials Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Diagnostic Imaging Clinical Trials Sales Value by Region (2019-2024)
5.1.3 Global Diagnostic Imaging Clinical Trials Sales Value by Region (2025-2030)
5.1.4 Global Diagnostic Imaging Clinical Trials Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Diagnostic Imaging Clinical Trials Sales Value, 2019-2030
5.2.2 North America Diagnostic Imaging Clinical Trials Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Diagnostic Imaging Clinical Trials Sales Value, 2019-2030
5.3.2 Europe Diagnostic Imaging Clinical Trials Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Diagnostic Imaging Clinical Trials Sales Value, 2019-2030
5.4.2 Asia Pacific Diagnostic Imaging Clinical Trials Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Diagnostic Imaging Clinical Trials Sales Value, 2019-2030
5.5.2 South America Diagnostic Imaging Clinical Trials Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Diagnostic Imaging Clinical Trials Sales Value, 2019-2030
5.6.2 Middle East & Africa Diagnostic Imaging Clinical Trials Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Diagnostic Imaging Clinical Trials Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Diagnostic Imaging Clinical Trials Sales Value
6.3 United States
6.3.1 United States Diagnostic Imaging Clinical Trials Sales Value, 2019-2030
6.3.2 United States Diagnostic Imaging Clinical Trials Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Diagnostic Imaging Clinical Trials Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Diagnostic Imaging Clinical Trials Sales Value, 2019-2030
6.4.2 Europe Diagnostic Imaging Clinical Trials Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Diagnostic Imaging Clinical Trials Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Diagnostic Imaging Clinical Trials Sales Value, 2019-2030
6.5.2 China Diagnostic Imaging Clinical Trials Sales Value by Type (%), 2023 VS 2030
6.5.3 China Diagnostic Imaging Clinical Trials Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Diagnostic Imaging Clinical Trials Sales Value, 2019-2030
6.6.2 Japan Diagnostic Imaging Clinical Trials Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Diagnostic Imaging Clinical Trials Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Diagnostic Imaging Clinical Trials Sales Value, 2019-2030
6.7.2 South Korea Diagnostic Imaging Clinical Trials Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Diagnostic Imaging Clinical Trials Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Diagnostic Imaging Clinical Trials Sales Value, 2019-2030
6.8.2 Southeast Asia Diagnostic Imaging Clinical Trials Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Diagnostic Imaging Clinical Trials Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Diagnostic Imaging Clinical Trials Sales Value, 2019-2030
6.9.2 India Diagnostic Imaging Clinical Trials Sales Value by Type (%), 2023 VS 2030
6.9.3 India Diagnostic Imaging Clinical Trials Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 ICON
7.1.1 ICON Profile
7.1.2 ICON Main Business
7.1.3 ICON Diagnostic Imaging Clinical Trials Products, Services and Solutions
7.1.4 ICON Diagnostic Imaging Clinical Trials Revenue (US$ Million) & (2019-2024)
7.1.5 ICON Recent Developments
7.2 Parexel
7.2.1 Parexel Profile
7.2.2 Parexel Main Business
7.2.3 Parexel Diagnostic Imaging Clinical Trials Products, Services and Solutions
7.2.4 Parexel Diagnostic Imaging Clinical Trials Revenue (US$ Million) & (2019-2024)
7.2.5 Parexel Recent Developments
7.3 BioTelemetry
7.3.1 BioTelemetry Profile
7.3.2 BioTelemetry Main Business
7.3.3 BioTelemetry Diagnostic Imaging Clinical Trials Products, Services and Solutions
7.3.4 BioTelemetry Diagnostic Imaging Clinical Trials Revenue (US$ Million) & (2019-2024)
7.3.5 ERT Recent Developments
7.4 ERT
7.4.1 ERT Profile
7.4.2 ERT Main Business
7.4.3 ERT Diagnostic Imaging Clinical Trials Products, Services and Solutions
7.4.4 ERT Diagnostic Imaging Clinical Trials Revenue (US$ Million) & (2019-2024)
7.4.5 ERT Recent Developments
7.5 McLaren
7.5.1 McLaren Profile
7.5.2 McLaren Main Business
7.5.3 McLaren Diagnostic Imaging Clinical Trials Products, Services and Solutions
7.5.4 McLaren Diagnostic Imaging Clinical Trials Revenue (US$ Million) & (2019-2024)
7.5.5 McLaren Recent Developments
7.6 Bioclinica
7.6.1 Bioclinica Profile
7.6.2 Bioclinica Main Business
7.6.3 Bioclinica Diagnostic Imaging Clinical Trials Products, Services and Solutions
7.6.4 Bioclinica Diagnostic Imaging Clinical Trials Revenue (US$ Million) & (2019-2024)
7.6.5 Bioclinica Recent Developments
7.7 ProScan Imaging
7.7.1 ProScan Imaging Profile
7.7.2 ProScan Imaging Main Business
7.7.3 ProScan Imaging Diagnostic Imaging Clinical Trials Products, Services and Solutions
7.7.4 ProScan Imaging Diagnostic Imaging Clinical Trials Revenue (US$ Million) & (2019-2024)
7.7.5 ProScan Imaging Recent Developments
7.8 Radiant Sage
7.8.1 Radiant Sage Profile
7.8.2 Radiant Sage Main Business
7.8.3 Radiant Sage Diagnostic Imaging Clinical Trials Products, Services and Solutions
7.8.4 Radiant Sage Diagnostic Imaging Clinical Trials Revenue (US$ Million) & (2019-2024)
7.8.5 Radiant Sage Recent Developments
7.9 Micron, Inc.
7.9.1 Micron, Inc. Profile
7.9.2 Micron, Inc. Main Business
7.9.3 Micron, Inc. Diagnostic Imaging Clinical Trials Products, Services and Solutions
7.9.4 Micron, Inc. Diagnostic Imaging Clinical Trials Revenue (US$ Million) & (2019-2024)
7.9.5 Micron, Inc. Recent Developments
7.10 Imaging Endpoints
7.10.1 Imaging Endpoints Profile
7.10.2 Imaging Endpoints Main Business
7.10.3 Imaging Endpoints Diagnostic Imaging Clinical Trials Products, Services and Solutions
7.10.4 Imaging Endpoints Diagnostic Imaging Clinical Trials Revenue (US$ Million) & (2019-2024)
7.10.5 Imaging Endpoints Recent Developments
7.11 Intrinsic Imaging
7.11.1 Intrinsic Imaging Profile
7.11.2 Intrinsic Imaging Main Business
7.11.3 Intrinsic Imaging Diagnostic Imaging Clinical Trials Products, Services and Solutions
7.11.4 Intrinsic Imaging Diagnostic Imaging Clinical Trials Revenue (US$ Million) & (2019-2024)
7.11.5 Intrinsic Imaging Recent Developments
7.12 Median Technologies
7.12.1 Median Technologies Profile
7.12.2 Median Technologies Main Business
7.12.3 Median Technologies Diagnostic Imaging Clinical Trials Products, Services and Solutions
7.12.4 Median Technologies Diagnostic Imaging Clinical Trials Revenue (US$ Million) & (2019-2024)
7.12.5 Median Technologies Recent Developments
8 Industry Chain Analysis
8.1 Diagnostic Imaging Clinical Trials Industrial Chain
8.2 Diagnostic Imaging Clinical Trials Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Diagnostic Imaging Clinical Trials Sales Model
8.5.2 Sales Channel
8.5.3 Diagnostic Imaging Clinical Trials Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Diagnostic Imaging Clinical Trials Market Trends
    Table 2. Diagnostic Imaging Clinical Trials Market Drivers & Opportunity
    Table 3. Diagnostic Imaging Clinical Trials Market Challenges
    Table 4. Diagnostic Imaging Clinical Trials Market Restraints
    Table 5. Global Diagnostic Imaging Clinical Trials Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Diagnostic Imaging Clinical Trials Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Diagnostic Imaging Clinical Trials Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Diagnostic Imaging Clinical Trials Product Type
    Table 9. Key Companies Time to Begin Mass Production of Diagnostic Imaging Clinical Trials
    Table 10. Global Diagnostic Imaging Clinical Trials Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Imaging Clinical Trials as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Diagnostic Imaging Clinical Trials Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Diagnostic Imaging Clinical Trials Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Diagnostic Imaging Clinical Trials Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Diagnostic Imaging Clinical Trials Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Diagnostic Imaging Clinical Trials Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Diagnostic Imaging Clinical Trials Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Diagnostic Imaging Clinical Trials Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Diagnostic Imaging Clinical Trials Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Diagnostic Imaging Clinical Trials Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Diagnostic Imaging Clinical Trials Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Diagnostic Imaging Clinical Trials Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Diagnostic Imaging Clinical Trials Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Diagnostic Imaging Clinical Trials Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Diagnostic Imaging Clinical Trials Sales Value by Region (2019-2024) & (%)
    Table 27. Global Diagnostic Imaging Clinical Trials Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Diagnostic Imaging Clinical Trials Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Diagnostic Imaging Clinical Trials Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Diagnostic Imaging Clinical Trials Sales Value, (2025-2030) & (US$ Million)
    Table 31. ICON Basic Information List
    Table 32. ICON Description and Business Overview
    Table 33. ICON Diagnostic Imaging Clinical Trials Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Diagnostic Imaging Clinical Trials Business of ICON (2019-2024)
    Table 35. ICON Recent Developments
    Table 36. Parexel Basic Information List
    Table 37. Parexel Description and Business Overview
    Table 38. Parexel Diagnostic Imaging Clinical Trials Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Diagnostic Imaging Clinical Trials Business of Parexel (2019-2024)
    Table 40. Parexel Recent Developments
    Table 41. BioTelemetry Basic Information List
    Table 42. BioTelemetry Description and Business Overview
    Table 43. BioTelemetry Diagnostic Imaging Clinical Trials Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Diagnostic Imaging Clinical Trials Business of BioTelemetry (2019-2024)
    Table 45. BioTelemetry Recent Developments
    Table 46. ERT Basic Information List
    Table 47. ERT Description and Business Overview
    Table 48. ERT Diagnostic Imaging Clinical Trials Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Diagnostic Imaging Clinical Trials Business of ERT (2019-2024)
    Table 50. ERT Recent Developments
    Table 51. McLaren Basic Information List
    Table 52. McLaren Description and Business Overview
    Table 53. McLaren Diagnostic Imaging Clinical Trials Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Diagnostic Imaging Clinical Trials Business of McLaren (2019-2024)
    Table 55. McLaren Recent Developments
    Table 56. Bioclinica Basic Information List
    Table 57. Bioclinica Description and Business Overview
    Table 58. Bioclinica Diagnostic Imaging Clinical Trials Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Diagnostic Imaging Clinical Trials Business of Bioclinica (2019-2024)
    Table 60. Bioclinica Recent Developments
    Table 61. ProScan Imaging Basic Information List
    Table 62. ProScan Imaging Description and Business Overview
    Table 63. ProScan Imaging Diagnostic Imaging Clinical Trials Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Diagnostic Imaging Clinical Trials Business of ProScan Imaging (2019-2024)
    Table 65. ProScan Imaging Recent Developments
    Table 66. Radiant Sage Basic Information List
    Table 67. Radiant Sage Description and Business Overview
    Table 68. Radiant Sage Diagnostic Imaging Clinical Trials Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Diagnostic Imaging Clinical Trials Business of Radiant Sage (2019-2024)
    Table 70. Radiant Sage Recent Developments
    Table 71. Micron, Inc. Basic Information List
    Table 72. Micron, Inc. Description and Business Overview
    Table 73. Micron, Inc. Diagnostic Imaging Clinical Trials Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Diagnostic Imaging Clinical Trials Business of Micron, Inc. (2019-2024)
    Table 75. Micron, Inc. Recent Developments
    Table 76. Imaging Endpoints Basic Information List
    Table 77. Imaging Endpoints Description and Business Overview
    Table 78. Imaging Endpoints Diagnostic Imaging Clinical Trials Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Diagnostic Imaging Clinical Trials Business of Imaging Endpoints (2019-2024)
    Table 80. Imaging Endpoints Recent Developments
    Table 81. Intrinsic Imaging Basic Information List
    Table 82. Intrinsic Imaging Description and Business Overview
    Table 83. Intrinsic Imaging Diagnostic Imaging Clinical Trials Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Diagnostic Imaging Clinical Trials Business of Intrinsic Imaging (2019-2024)
    Table 85. Intrinsic Imaging Recent Developments
    Table 86. Median Technologies Basic Information List
    Table 87. Median Technologies Description and Business Overview
    Table 88. Median Technologies Diagnostic Imaging Clinical Trials Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Diagnostic Imaging Clinical Trials Business of Median Technologies (2019-2024)
    Table 90. Median Technologies Recent Developments
    Table 91. Key Raw Materials Lists
    Table 92. Raw Materials Key Suppliers Lists
    Table 93. Diagnostic Imaging Clinical Trials Downstream Customers
    Table 94. Diagnostic Imaging Clinical Trials Distributors List
    Table 95. Research Programs/Design for This Report
    Table 96. Key Data Information from Secondary Sources
    Table 97. Key Data Information from Primary Sources
    Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Diagnostic Imaging Clinical Trials Product Picture
    Figure 2. Global Diagnostic Imaging Clinical Trials Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Diagnostic Imaging Clinical Trials Sales Value (2019-2030) & (US$ Million)
    Figure 4. Diagnostic Imaging Clinical Trials Report Years Considered
    Figure 5. Global Diagnostic Imaging Clinical Trials Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Diagnostic Imaging Clinical Trials Revenue in 2023
    Figure 7. Diagnostic Imaging Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Radiological Imaging Diagnosis Picture
    Figure 9. Non-radioactive Imaging Diagnosis Picture
    Figure 10. Global Diagnostic Imaging Clinical Trials Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Diagnostic Imaging Clinical Trials Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Hospital
    Figure 13. Product Picture of Clinic
    Figure 14. Product Picture of Others
    Figure 15. Global Diagnostic Imaging Clinical Trials Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Diagnostic Imaging Clinical Trials Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America Diagnostic Imaging Clinical Trials Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America Diagnostic Imaging Clinical Trials Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe Diagnostic Imaging Clinical Trials Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe Diagnostic Imaging Clinical Trials Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific Diagnostic Imaging Clinical Trials Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific Diagnostic Imaging Clinical Trials Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America Diagnostic Imaging Clinical Trials Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America Diagnostic Imaging Clinical Trials Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa Diagnostic Imaging Clinical Trials Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa Diagnostic Imaging Clinical Trials Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions Diagnostic Imaging Clinical Trials Sales Value (%), (2019-2030)
    Figure 28. United States Diagnostic Imaging Clinical Trials Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States Diagnostic Imaging Clinical Trials Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States Diagnostic Imaging Clinical Trials Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe Diagnostic Imaging Clinical Trials Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe Diagnostic Imaging Clinical Trials Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe Diagnostic Imaging Clinical Trials Sales Value by Application (%), 2023 VS 2030
    Figure 34. China Diagnostic Imaging Clinical Trials Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China Diagnostic Imaging Clinical Trials Sales Value by Type (%), 2023 VS 2030
    Figure 36. China Diagnostic Imaging Clinical Trials Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan Diagnostic Imaging Clinical Trials Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan Diagnostic Imaging Clinical Trials Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan Diagnostic Imaging Clinical Trials Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea Diagnostic Imaging Clinical Trials Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea Diagnostic Imaging Clinical Trials Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea Diagnostic Imaging Clinical Trials Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia Diagnostic Imaging Clinical Trials Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Diagnostic Imaging Clinical Trials Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia Diagnostic Imaging Clinical Trials Sales Value by Application (%), 2023 VS 2030
    Figure 46. India Diagnostic Imaging Clinical Trials Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India Diagnostic Imaging Clinical Trials Sales Value by Type (%), 2023 VS 2030
    Figure 48. India Diagnostic Imaging Clinical Trials Sales Value by Application (%), 2023 VS 2030
    Figure 49. Diagnostic Imaging Clinical Trials Industrial Chain
    Figure 50. Diagnostic Imaging Clinical Trials Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS